REPORT: [Reuters] – Pfizer Inc has WITHDRAWN an application for emergency-use authorization of its COVID-19 vaccine in India, after FAILING TO MEET DRUG REGULATORS DEMAND for a local safety and immunogenicity study…
— Chuck Callesto (@ChuckCallesto) February 16, 2022
Views: